Skip to main content

LENSAR, Inc.

LNSR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001320350

No open-market purchases or sales by LENSAR, Inc. insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $25.2M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding LENSAR, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of LNSR: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders3735−2
Shares6.03M6.00M−31.2K (−0.5%)
Value$39.0M$33.3M−$5.73M (−14.7%)

New holders (4)

Institutions that held LENSAR, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to LNSR in Q3 2022
InstitutionSharesValue% of portfolio
Main Street Research LLC43,489$241.0K0.05%
Charles Schwab Investment Management Inc12,582$70.0K0.00%
Simplex Trading, LLC800$4.00K0.00%
Providence Capital Advisors, LLC182$1.00K0.00%

Sold out (6)

Institutions that held LENSAR, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of LNSR in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Federation des caisses Desjardins du Quebec257$1.67K
Captrust Financial Advisors155$1.00K
Rockefeller Capital Management L.P.228$1.00K
Joseph P. Lucia & Associates, LLC7$0
XTX Topco Ltd18,463$0
Nuveen Asset Management, LLC17,865–